MedPath
HSA Approval

CUBEREC 80 FILM-COATED TABLETS 80 MG

SIN17170P

CUBEREC 80 FILM-COATED TABLETS 80 MG

CUBEREC 80 FILM-COATED TABLETS 80 MG

January 24, 2025

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

C09CA03

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

DR. REDDY'S LABORATORIES LTD.

Active Ingredients

VALSARTAN

80.00 MG

Valsartan

Documents

Package Inserts

Cuberec 80 Film-Coated Tablets 80 mg PI.pdf

Approved: January 24, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CUBEREC 80 FILM-COATED TABLETS 80 MG - HSA Approval | MedPath